In the six months to last December, 42 of Australia's pharmaceutical companies spent A$16.4 million ($11.5 million) in travel, accommodation and entertainment. Almost 400,000 health professionals received the hospitality at more than 14,000 separate events. The figures are published for the first time in a report released by the country's main drug company trade group, Medicines Australia, and were produced on the requirement of the Australian Competition and Consumer Commission, as part of the association's Code of Conduct.
Consumer advocates say there is no doubt the pharmaceutical companies are trying to buy the opinions of doctors and they want the largesse to stop, reports the local ABC News. Christopher Zinn, the spokesman for the consumer group Choice, speaking on the television program The World Today, stated: "we think it's fair enough for [the drug companies] to talk to doctors, to give them information, but actually there are other systems, the national prescribing service for example, sends out people to talk to doctors to give them information. Now that's something that's totally independent."
Industry defends its position
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze